Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.5.1.2 (
DNA ligase
)
2,749
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Two
DNA ligase
activities have been separated, purified, and characterized. The resolution of the two enzymes from crude extracts was initially achieved through
Polymin P
precipitation. The ligation activity precipitating with the nucleic acids on treatment with
Polymin P
is designated as DNA ligase I, and an activity remaining in the supernatant fraction, as
DNA ligase
II. DNA ligase I and II are ATP and Mg2+-dependent enzymes with pH optima of 7.8 and 8.0 and isoelectric points of 6.9 and 7.6, respectively. The purified I and II
DNA ligase
activities have molecular weights of 83,000 and 89,000, respectively. Both activities are inhibited by dATP and inorganic pyrophosphate. However, in the presence of optimum rATP levels, dATP stimulates
DNA ligase
II activity, whereas DNA ligase I is inhibited under the same conditions. Both activities are DNA specific and ligation follows reaction steps similar to those described for the Escherichia coli
DNA ligase
.
...
PMID:Purification and properties of two DNA ligases from human placenta. 300 51